tbuckley/cabot-search huggingface dataset:
An experimental approach to linguistic representation
Authors: Holly P. Branigan, Martin J. Pickering
Journal: Behavioral and Brain Sciences (2016)

Within the cognitive sciences, most researchers assume that it is the job of linguists to investigate how language is represented, and that they do so largely by building theories based on explicit judgments about patterns of acceptability - whereas it is the task of psychologists to determine how language is processed, and that in doing so, they do not typically question the linguists' representational assumptions. We challenge this division of labor by arguing that structural priming provides an implicit method of investigating linguistic representations that should end the current reliance on acceptability judgments. Moreover, structural priming has now reached sufficient methodological maturity to provide substantial evidence about such representations. We argue that evidence from speakers' tendency to repeat their own and others' structural choices supports a linguistic architecture involving a single shallow level of syntax connected to a semantic level containing information about quantification, thematic relations, and information structure, as well as to a phonological level. Many of the linguistic distinctions often used to support complex (or multilevel) syntactic structure are instead captured by semantics; however, the syntactic level includes some specification of "missing" elements that are not realized at the phonological level. We also show that structural priming provides evidence about the consistency of representations across languages and about language development. In sum, we propose that structural priming provides a new basis for understanding the nature of language.
Venous Thromboembolism Is Associated with Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Natasha Kekre, Haesook T. Kim, Vincent T. Ho, Corey S Cutler, Philippe Armand, Sarah Nikiforow, Edwin P. Alyea, Robert J. Soiffer, Joseph H Antin, Jean M. Connors, John Koreth
Journal: Blood (2015)
Pediatric ALL-like Therapy in Adults with T-Cell Lymphoblastic Lymphoma: Results of the Graall-Lysa LL03 Study
Authors: Stephane Lepretre, Aurore Touzart, Thomas Vermeulin, Jean-Michel Picquenot, Aline Tanguy-Schmidt, Gilles Salles, Thierry Lamy, Marie C Bene, Emmanuel Raffoux, Françoise Huguet, Patrice Chevallier, Serge Bologna, Reda Bouabdallah, Jacques Benichou, Josette Briere, Anne Moreau, Valerie Simon, Stephanie Seris, Carlos Graux, Vahid Asnafi, Norbert Ifrah, Elizabeth Macintyre, Herve Dombret
Journal: Blood (2014)
Linear Relationship Between Lymphocyte Subpopulations Counts in Peripheral Blood and Buffy-Coat during Extracorporeal Photopheresis in Patients with Graft-Versus-Hot-Disease Using an Off-Line System
Authors: Cristina Pascual, Mari­a Jose Penalva, Ana Pérez-Corral, Laura Solán, Sara Redondo, Elena González-Arias, Mariana Bastos, Mi Kwon, Jorge Gayoso, David Serrano, Javier Anguita, Jose Luis Diez-Martin
Journal: Blood (2014)
Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia
Authors: Jae H Park, Stephen S. Chung, Young Rock Chung, Helen Won, Julie Teruya-Feldstein, Michael Berger, Talal T Khawaja, Mario E Lacouture, Ross L. Levine, Omar Abdel-Wahab, Martin S Tallman
Journal: Blood (2013)
A “canonical” Npm1 mutation Knock-in Mouse Model Revealed Subtle but Definitive Myeloid Expansion with Poor HSC Niche Interaction
Authors: Wen-Chien Chou, Shiu-Huey Chou, Ji-Shain Chiou, Bor-Sheng Ko, Shu-Wha Lin, Yueh-Chwen Hsu, Hwei-Fang Tien
Journal: Blood (2011)
Smoke-free legislation and its impact on paediatric respiratory health
Authors: Timor Faber, Aziz Sheikh, Jasper V. Been
Journal: European Respiratory Journal (2016)

We read with great interest the study by Vardavas et al. [1] confirming the independent and interacting roles of tobacco smoke exposure during pregnancy and after birth in the development of respiratory diseases. Protecting children from tobacco smoke exposure via smoke-free legislation can benefit respiratory health <http://ow.ly/FlHe3033Xr9>
Lenalidomide (Len) in Combination with Rituximab (R) Demonstrated Early Evidence of Efficacy in a Phase I/II Study in Relapsed/Refractory Mantle Cell Lymphoma (MCL).
Authors: Michael Wang, Luis Fayad, Frederick Hagemeister, Sattva Neelapu, Barry Samuels, Felipe Samanigo, Barbara Pro, Qing Yi, Neda Bell, Catriona Byrne, Pam Weaver, Kim Hartig, Robert Knight, Jerry Zeldis, Larry Kwak, Jorge Romaguera
Journal: Blood (2007)
Swimming, aerobics, and racquet sports are linked to lowest risk of cardiovascular death
Authors: Jacqui Wise
Journal: BMJ (2016)

Swimming, racquet sports, and aerobics seem to be the best forms of exercise for reducing the risk of death from heart disease and stroke, research published in the British Journal of Sports Medicine has found.1

The researchers analysed data from the Health Survey for England and the Scottish Health survey from 1994 to 2008. The cohort included 80 306 adults with an average age of 52, of whom 54% were women. Overall, 44% of the participants met the national guidelines on physical activity. The participants were asked …
The Prognostic Impact and Stability of IDH2 Mutation and the Insufficiency of the Mutation Alone for Leukemogenesis In Adult Patients with Acute Myeloid Leukemia
Authors: Weng-Chi Lei, Wen-Chien Chou, Bor-Shen Ko, Hsin-An Hou, Hwei-Fang Tien
Journal: Blood (2010)
TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD
Authors: Elena Provasi, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria Chu, David E Paschon, Lei Zhang, Jurgen Kuball, Barbara Camisa, Attilio Bondanza, Giulia Casorati, Maurilio Ponzoni, Fabio Ciceri, Claudio Bordignon, Philip D. Greenberg, Michael C. Holmes, Philip D. Gregory, Luigi Naldini, Chiara Bonini
Journal: Blood (2011)
Use of the Serum Free Light Chain Assay in Assessment of Response to Therapy in Multiple Myeloma: Validation of Recently Proposed Response Criteria in a Prospective Clinical Trial of Lenalidomide Plus Dexamethasone for Newly Diagnosed Multiple Myeloma.
Authors: Shaji Kumar, Morie A. Gertz, Suzanne R. Hayman, Martha Q. Lacy, Angela Dispenzieri, Steve R. Zeldenrust, John A. Lust, Philip R. Greipp, Robert A. Kyle, Rafael Fonseca, S. Vincent Rajkumar
Journal: Blood (2005)
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer
Authors: Sarah R. Hosford, Lloye M. Dillon, Stephanie J. Bouley, Rachele Rosati, Wei Yang, Vivian S. Chen, Eugene Demidenko, Rocco P. Morra, Todd W. Miller
Journal: Clinical Cancer Research (2016)

Abstract Purpose: Determine the roles of the PI3K isoforms p110α and p110β in PTEN-deficient, estrogen receptor α (ER)-positive breast cancer, and the therapeutic potential of isoform-selective inhibitors. Experimental Design: Anti-estrogen-sensitive and -resistant PTEN-deficient, ER+ human breast cancer cell lines, and mice bearing anti-estrogen–resistant xenografts were treated with the anti-estrogen fulvestrant, the p110α inhibitor BYL719, the p110β inhibitor GSK2636771, or combinations. Temporal response to growth factor receptor–initiated signaling, growth, apoptosis, predictive biomarkers, and tumor volumes were measured. Results: p110β primed cells for response to growth factor stimulation. Although p110β inhibition suppressed cell and tumor growth, dual targeting of p110α/β enhanced apoptosis and provided sustained tumor response. The growth of anti-estrogen–sensitive cells was inhibited by fulvestrant, but fulvestrant inconsistently provided additional therapeutic effects beyond PI3K inhibition alone. Treatment-induced decreases in phosphorylation of AKT and Rb were predictive of therapeutic response. Short-term drug treatment induced tumor cell apoptosis and proliferative arrest to induce tumor regression, whereas long-term treatment only suppressed proliferation to provide durable regression. Conclusions: p110β is the dominant PI3K isoform in PTEN-deficient, ER+ breast cancer cells. Upon p110β inhibition, p110α did not induce significant reactivation of AKT, but combined targeting of p110α/β most effectively induced apoptosis in vitro and in vivo and provided durable tumor regression. Because apoptosis and tumor regression occurred early but not late in the treatment course, and proliferative arrest was maintained throughout treatment, p110α/β inhibitors may be considered short-term cytotoxic agents and long-term cytostatic agents. Clin Cancer Res; 23(11); 2795–805. ©2016 AACR.
Minimal Disseminated Disease (MDD) in BM of Childhood T-Cell Lymphoblastic Lymphoma (Stage III), Detected by Flow Cytometry (FC) and Real Time Quantitative Polymerase Chain Reaction (RQ-PCR).
Authors: Batia Stark, Drorit Luria, Sigal Manor, Taly Ronen, Yona Kodman, Gali Avrahami, Isaac Yaniv, Smadar Avigad
Journal: Blood (2005)
Prediction of Cytogenetic Response to Second Generation TKI Therapy in CML Chronic Phase Patients Who Have Failed Imatinib Therapy and Early Identification of Factors That Influence Survival
Authors: Dragana Milojkovic, Marco Bua, Jane F Apperley, Kasia Kozlowski, Jamshid Sorori, Letizia Foroni, Alistair Reid, Jiri Pavlu, Katy Rezvani, Francesco Dazzi, Eduardo Olavarria, Matthias Klammer, John M Goldman, David Marin
Journal: Blood (2008)
A Phase I–II Trial of Bortezomib (Velcade) (Vc) and Oral Cyclophosphamide (CY) Plus Prednisone (P) for Relapsed/Refractory Multiple Myeloma (MM).
Authors: Donna E. Reece, Giovanni Piza, Suzanne Trudel, Christine Chen, Joseph R. Mikhael, A. Keith Stewart
Journal: Blood (2005)
Evaluation of the Role of PlGF and the Therapeutic Potential of Anti-PlGF in BCR/ABL+ Leukemia.
Authors: Sonja Loges, Thomas Schmidt, Maria Kleppe, Kim De Keersmaecker, Marc Tjwa, Christa Maes, Christiane DeWolf-Peeters, Geert Carmeliet, Jan Cools, Jean-Marie Stassen, Peter Carmeliet
Journal: Blood (2008)
Generation of a Fully Human High Affinity Neutralizing Antibody Against MT-SP1/Matriptase and Its Potential Role for the Treatment of B Cell Lymphoma.
Authors: Ian N. Foltz, Stan K. Morkowski, Caroline D. Scatena, Peter Ling, Hao Li, Ying Liu, Chadwick T. King, Jaspal Kang, Kathy Manchulenko, Lisa Perkins, Sukhbir Kang, Minchao Chen, Wayne Godfrey, Bruce Keyt, Jennifer H. Richardson
Journal: Blood (2005)
Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)
Authors: Pierre Fenaux, Aristotles Giagounidis, Odile Beyne-Rauzy, Ghulam Mufti, Moshe Mittelman, Petra Muus, Peter te Boekhorst, Guillermo Sanz, Mario Cazzola, Jay Backstrom, Tommy Fu, Eva Hellström-Lindberg
Journal: Blood (2010)
Comparative Study Between Relative and Absolute BCR-ABL Transcript Quantification by Real Time PCR in Chronic Myeloid Leukemia
Authors: Paula Oliveira Montandon Hokama, Juliana Capannacci, Newton Key Hokama, Kozue Miyashiro, Fernando Lopes Alberto, Vergilio AntÃ’nio Renzi Colturato, Lidia Raquel Carvalho
Journal: Blood (2008)
Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction
Authors: Margaret V. Ragni, Donna DiMichele, Charles R.M. Hay, Lynn M. Malec, Craig D. Seaman, Jonathan Yabes, Jie Li, Saulius Butenas, Kathleen Brumel-Ziedins
Journal: Blood (2014)
Reciprocal Activation of GATA-1 and PU.1 Marks Initial Specification of Hematopoietic Stem Cells into Myelo-Erythroid and Myelo-Lymphoid Lineages.
Authors: Yojiro Arinobu, Shin-ichi Mizuno, Yong Chong, Hirokazu Shigematsu, Tadafumi Iino, Hiromi Iwasaki, Thomas Graf, Robin Mayfield, Susan Chan, Philippe Kastner, Koichi Akashi
Journal: Blood (2007)
Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice
Authors: Mohamad Mohty, Evangelos Terpos, Maria-Victoria Mateos, Antonio Palumbo, Sandra Lejniece, Meral Beksac, Mohamed Amine Bekadja, Wojciech Legiec, Meletios Dimopoulos, Svetlana Stankovic, Maria Soledad Durán, Valerio De Stefano, Alessandro Corso, Yulia Kochkareva, Edward Laane, Christian Berthou, Hans-Juergen Salwender, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, João Da Silva, Vernon Louw, Damir Nemet, Zita Borbényi, Uri Abadi, Robert Schou Pedersen, Peter Cernelc, Anna Potamianou, Catherine Couturier, Robert Olie, Caroline Feys, Florence Thoret-Bauchet, Mario Boccadoro
Journal: Blood (2015)
NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group
Authors: Norio Shiba, Tomohiko Taki, Myoung-ja Park, Chisato Murata, Kentaro Oki, Hitoshi Ichikawa, Akira Shimada, Takashi Kanazawa, Manabu Sotomatsu, Ken Tabuchi, Souichi Adachi, Akio Tawa, Keizo Horibe, Masahiro Tsuchida, Ryoji Hanada, Ichiro Tsukimoto, Hirokazu Arakawa, Yasuhide Hayashi
Journal: Blood (2011)
Microarray-Based Genomic Profiling Facilitates Genetic Subgrouping and Detects Critical Submicroscopic Aberrations Associated with Prognosis in Pediatric Acute Lymphoblastic Leukemia (ALL)
Authors: Marilyn L Slovak, Ya-Hsuan Hsu, Jennifer A Otani-Rosa, Jennifer A Jahn, Zunyan Dai, Marc Sanidad, Philip N Mowrey, Dan Jones
Journal: Blood (2012)
The Glucocorticoid Receptor Plays an Important Role in Controlling Lipid Metabolism During Erythroid Maturation
Authors: Valentina Tirelli, Francesca Masiello, Fabrizio Martelli, Fiorella Ciaffoni, Giovanni Migliaccio, Carolyn F. Whitsett, David Ray, Anna Rita F Migliaccio
Journal: Blood (2012)
Surgery and Hepatocellular Carcinoma
Authors: Nobuhisa Akamatsu, Umberto Cillo, Alessandro Cucchetti, Matteo Donadon, Antonio Daniele Pinna, Guido Torzilli, Norihiro Kokudo
Journal: Liver Cancer (2016)

The optimal surgical strategy for hepatocellular carcinoma (HCC) is under active debate. Bio-markers of the liver functional reserve as well as volumetric analysis of the future liver remnant are essential for safe liver resection of HCC. The present algorithms applied to surgical strategies for HCC are not ideal because many patients who could potentially undergo safe resection are deemed liver transplant candidates in Western countries, whereas the opposite is the case in Eastern countries. In addition, there is too much focus on expanded criteria for patients with HCC to undergo liver transplantation. The transplantation benefit for patients with HCC should be considered based not only on the individual's benefit, but also on the effect of other patients waiting for LT for other indications.
Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.
Authors: Christian Rose, Sabine Brechignac, Dominique Vassilief, Odile Beyne-Rauzy, A. Stamatoullas, Dalila Larbaa, Agnes Guerci, L. Roy, Lydia Dumazert, Beatrice Mahe, S. Cheze, Bruno Quesnel, Dominique Bordessoule, Francois Dreyfus, Pierre Fenaux
Journal: Blood (2007)
A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results
Authors: Mark A. Schroeder, Jaebok Choi, Matthew L Cooper, David Schwab, Sarah Willey, Jingxia (Esther) Liu, Matthew Holt, Linda Eissenberg, Iskra Pusic, Armin Ghobadi, Rizwan Romee, John S. Welch, Keith Stockerl-Goldstein, Camille N. Abboud, Ravi Vij, Geoffrey L. Uy, Peter Westervelt, John F Dipersio
Journal: Blood (2015)
Frequent Involvement of PVT1 in Multiple Myeloma Carrying 8q24 Rearrangement and Identification of Novel PVT1-NBEA Chimeric Gene,
Authors: Hisao Nagoshi, Tomohiko Taki, Ichiro Hanamura, Masakazu Nitta, Takemi Otsuki, Kazuhiro Nishida, Keiko Okuda, Natsumi Sakamoto, Satoru Kobayashi, Mio Yamamoto, Yasuhiko Tsutsumi, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Junya Kuroda, Masafumi Taniwaki
Journal: Blood (2011)
Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains
Authors: Douglas M. Zeppenfeld, Matthew Simon, J. Douglas Haswell, Daryl D’Abreo, Charles Murchison, Joseph F. Quinn, Marjorie R. Grafe, Randall L. Woltjer, Jeffrey Kaye, Jeffrey J. Iliff
Journal: JAMA Neurology (2016)

<h3>Importance</h3> Cognitive impairment and dementia, including Alzheimer disease (AD), are common within the aging population, yet the factors that render the aging brain vulnerable to these processes are unknown. Perivascular localization of aquaporin-4 (AQP4) facilitates the clearance of interstitial solutes, including amyloid-β, through the brainwide network of perivascular pathways termed the<i>glymphatic system</i>, which may be compromised in the aging brain. <h3>Objectives</h3> To determine whether alterations in AQP4 expression or loss of perivascular AQP4 localization are features of the aging human brain and to define their association with AD pathology. <h3>Design, Setting, and Participants</h3> Expression of AQP4 was analyzed in postmortem frontal cortex of cognitively healthy and histopathologically confirmed individuals with AD by Western blot or immunofluorescence for AQP4, amyloid-β 1-42, and glial fibrillary acidic protein. Postmortem tissue and clinical data were provided by the Oregon Health and Science University Layton Aging and Alzheimer Disease Center and Oregon Brain Bank. Postmortem tissue from 79 individuals was evaluated, including cognitively intact “young” individuals aged younger than 60 years (range, 33-57 years), cognitively intact “aged” individuals aged older than 60 years (range, 61-96 years) with no known neurological disease, and individuals older than 60 years (range, 61-105 years) of age with a clinical history of AD confirmed by histopathological evaluation. Forty-eight patient samples (10 young, 20 aged, and 18 with AD) underwent histological analysis. Sixty patient samples underwent Western blot analysis (15 young, 24 aged, and 21 with AD). <h3>Main Outcomes and Measures</h3> Expression of AQP4 protein, AQP4 immunoreactivity, and perivascular AQP4 localization in the frontal cortex were evaluated. <h3>Results</h3> Expression of AQP4 was associated with advancing age among all individuals (<i>R2</i> = 0.17;<i>P</i> = .003). Perivascular AQP4 localization was significantly associated with AD status independent of age (OR, 11.7 per 10% increase in localization; z = −2.89;<i>P</i> = .004) and was preserved among eldest individuals older than 85 years of age who remained cognitively intact. When controlling for age, loss of perivascular AQP4 localization was associated with increased amyloid-β burden (<i>R2</i> = 0.15;<i>P</i> = .003) and increasing Braak stage (<i>R2</i> = 0.14;<i>P</i> = .006). <h3>Conclusions and Relevance</h3> In this study, altered AQP4 expression was associated with aging brains. Loss of perivascular AQP4 localization may be a factor that renders the aging brain vulnerable to the misaggregation of proteins, such as amyloid-β, in neurodegenerative conditions such as AD.
MMSET Stimulates Myeloma Cell Growth Through MicroRNA-Mediated Modulation of c-MYC
Authors: Dong-Joon Min, Marianne Kim, Teresa Ezponda, Christine Will, Eva Martinez-Garcia, Relja Popovic, Kojo S.J. Elenitoba-Johnson, Basrur Venkatesha, Jonathan D. Licht
Journal: Blood (2011)
Wales approves new hepatitis C drug while England deliberates
Authors: Piotr Ozieranski, Lawrence King
Journal: BMJ (2016)

A new drug for hepatitis C has been approved for use in Wales ahead of its appraisal by the National Institute for Health and Care Excellence (NICE) for use in England and is being made available to patients in line with the Welsh strategy to prevent the transmission of the virus.

The All Wales Medicines Strategy Group recommended Epclusa (sofosbuvir with velpatasvir) for use in the NHS in Wales after concluding that the treatment would be cost effective for most patients.1 The treatment will be funded under the Welsh patient access scheme. The price proposed by its manufacturer, Gilead, is confidential but likely to involve a discount from the UK list price of about £40 000 (€47 000; $50 000) …
Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant
Authors: Mirat Shah, Bridget Ory Dickerson, Bipin N. Savani, Lora Thomas, Wichai Chinratanalab, Brian Engelhardt, Stacey Goodman, John P Greer, Adetola A. Kassim, Salyka Sengsayadeth, Madan Jagasia
Journal: Blood (2014)
GPI-AP Deficient Cells Detected Exclusively in T Cells in Patients with Aplastic Anemia: Evidence against An Escape Mechanism for the Initial Proliferation of PIG-AMutant Hematopoietic Stem Cells.
Authors: Takamasa Katagiri, Zhirong Qi, Yu Kiyu, Naomi Sugimori, J. Luis Espinoza, Akiyoshi Takami, Shigeki Ohtake, Shinji Nakao
Journal: Blood (2009)
Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience
Authors: Costanza Paoletti, Lodovico Balducci, Ivette Boler, Mihaela Popa-McKiver, Martine Externann, Jyotishankar Raychaudury, Claudio Anasetti, Hugo F. Fernandez, Daniel Sullivan, William S. Dalton, Teresa Field, Ernesto Ayala, Mohamed A Kharfan-Dabaja, Lia Perez, Janelle Perkins, William E. Janssen, John Harris, Michael Schell, Rachna Kapoor, Melissa Alsina, J. Leonel Ochoa-Bayona
Journal: Blood (2008)
Baseline Metabolic Tumor Volume Is Predictive of Patient Outcome in Diffuse Large B Cell Lymphoma
Authors: Rene-Olivier Casasnovas, Myriam Sasanelli, Alina Berriolo-Riedinger, Franck Morschhauser, Emmanuel Itti, Damien Huglo, Annibale Versari, Bertrand Coiffier, Michel Meignan
Journal: Blood (2012)
Role of hSET1 Complex in Epigenetic Controls of HoxB4 Expression and Development of Hematopoietic Stem Cells
Authors: Changwang Deng, Ying Li, Shermi Liang, Tal Salz, Yi Qiu, Robert Roeder, Keji Zhao, Jorg Bungert, Suming Huang
Journal: Blood (2011)
Postremission Therapy with an Allogeneic Transplantation from an HLA-Matched Family Donor Seems To Overcome the Negative Prognostic Impact of FLT3-ITD in Younger Patients with Acute Myeloid Leukemia Exhibiting a Normal Karyotype.
Authors: Richard F. Schlenk, Jürgen Krauter, Stefan Fröhling, Daniela Späth, Irina Schäfer, Stefan Hein, Hartmut Döhner, Arnold Ganser, Konstanze Döhner
Journal: Blood (2005)
Clinical Impact of TP53 Mutations in Patients with MDS and Isolated Deletion 5(q) Treated with Lenalidomid: Results from the German Prospective Le-Mon-5 Trial
Authors: Maximilian Mossner, Johann Christoph Jann, Evi Launiger-Lörsch, Daniel Nowak, Uwe Platzbecker, Aristoteles Giagounidis, Katharina Götze, Anne Letsch, Detlef Haase, Katayoon Shirneshan, Richard F. Schlenk, Torsten Haferlach, Gesine Bug, Michael Lübbert, Arnold Ganser, Verena Nowak, Jovita Pressler, Julia Obländer, Stephanie Fey, Nadine Müller, Georgia Metzgeroth, Wolf-Karsten Hofmann, Ulrich Germing, Florian Nolte
Journal: Blood (2014)
High Dose Plerixafor Is Safe and Mobilizes Higher Numbers of CD34+ Cells Compared with Standard Dose Plerixafor
Authors: Jeremy M Pantin, Xin Tian, Matthew M. Hsieh, Lisa Cook, Theresa Donohue, Elena Cho, Aleah Smith, Robert Reger, Thomas Trischman, Hanh Khuu, Richard Childs
Journal: Blood (2012)